RAPT — Rapt Therapeutics Share News
0.000.00%
Last trade - 00:00Rapt plummets on discontinuation of experimental drug for eczema and asthma
Rapt Therapeutics Inc Expected To Post A Loss Of 56 Cents A Share: Earnings Preview
Brief: Rapt Therapeutics Q2 Net Income USD -27.663 Million
Rapt Therapeutics Inc Expected To Post A Loss Of 72 Cents A Share: Earnings Preview
U.S. STOCKS ON THE MOVE-Hilton Grand Vacations, natgas firms, Silvaco
U.S. STOCKS ON THE MOVE-Gold miners, Energy Transfer, Aercap
RAPT Therapeutics falls as co to stop development of lead inflammation drug
Brief: Rapt Therapeutics Q1 Net Income USD -30.521 Million
Rapt Therapeutics Inc Expected To Post A Loss Of 81 Cents A Share: Earnings Preview
Rapt Therapeutics Inc Reports Results For The Quarter Ended In December: Earnings Summary
Rapt Therapeutics Inc Expected To Post A Loss Of 80 Cents A Share: Earnings Preview
Brief: Rapt Therapeutics Q4 Net Income USD -30.876 Million
U.S. RESEARCH ROUNDUP-Home Depot, Palo Alto Networks, Wendys
U.S. STOCKS ON THE MOVE-Barrick Gold, Western Midstream, ARS Pharma
Rapt Therapeutics hits record low as FDA places two drug trials on hold
U.S. STOCKS ON THE MOVE-Allegion, Norfolk Southern, Intuitive Machines
U.S. STOCKS ON THE MOVE-Medtronic, Equitrans Midstream, Super Micro
Rapt Therapeutics down as FDA places hold on two mid-stage studies
FDA puts on hold two Rapt Therapeutics mid-stage drug trials (updated)